USE OF THE COMPOUND 2-[3-(2-CHLOROETHYL)-3-NITROSOUREIDO]-1,3-PROPANEDIOL FOR TREATING HER2-POSITIVE TUMORS EXPERIMENTALLY

FIELD: medicine.SUBSTANCE: invention relates to medicine, namely to oncology. Disclosed is use of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol for treating HER2-positive tumors experimentally in dose of 15-20 mg/kg parenterally.EFFECT: in mice FVB/N with spontaneous or transplantable HER2-p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Vasileva Olesya Aleksandrovna, Egormin Petr Andreevich, Filatova Larisa Valentinovna, Senchik Konstantin Yurevich, Stukov Aleksandr Nikolaevich, Bakhidze Elena Villevna, Tochilnikov Grigorij Viktorovich, Yurova Mariya Nikolaevna, Semiglazova Tatyana Yurevna, Bespalov Vladimir Grigorevich, Majdin Mikhail Aleksandrovich, Konstantinov Leonid Vladimirovich, Panchenko Andrej Vladimirovich, Plakhov Evgenij Aleksandrovich, Tyndyk Margarita Leonidovna, Poltoratskij Artem Nikolaevich, Semenov Aleksandr Leonidovich, Ivantsov Aleksandr Olegovich, Vershinina Sofiya Fatkhutdinovna, Latipova Dilorom Khamidovna, Anisimov Vladimir Nikolaevich, Chubenko Vyacheslav Andreevich, Kozyavin Nikita Aleksandrovich, Kireeva Galina Sergeevna
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Vasileva Olesya Aleksandrovna
Egormin Petr Andreevich
Filatova Larisa Valentinovna
Senchik Konstantin Yurevich
Stukov Aleksandr Nikolaevich
Bakhidze Elena Villevna
Tochilnikov Grigorij Viktorovich
Yurova Mariya Nikolaevna
Semiglazova Tatyana Yurevna
Bespalov Vladimir Grigorevich
Majdin Mikhail Aleksandrovich
Konstantinov Leonid Vladimirovich
Panchenko Andrej Vladimirovich
Plakhov Evgenij Aleksandrovich
Tyndyk Margarita Leonidovna
Poltoratskij Artem Nikolaevich
Semenov Aleksandr Leonidovich
Ivantsov Aleksandr Olegovich
Vershinina Sofiya Fatkhutdinovna
Latipova Dilorom Khamidovna
Anisimov Vladimir Nikolaevich
Chubenko Vyacheslav Andreevich
Kozyavin Nikita Aleksandrovich
Kireeva Galina Sergeevna
description FIELD: medicine.SUBSTANCE: invention relates to medicine, namely to oncology. Disclosed is use of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol for treating HER2-positive tumors experimentally in dose of 15-20 mg/kg parenterally.EFFECT: in mice FVB/N with spontaneous or transplantable HER2-positive breast cancer 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (intraperitoneally) once caused partial and even complete temporary regression of tumor; invention extends the range of products for treating HER2-positive tumors, increases the therapeutic effect in suppressing tumor growth.1 cl, 2 dwg, 6 tbl, 3 ex Изобретение относится к медицине, а именно к онкологии. Предложено применение 2-[3-(2-хлорэтил)-3-нитрозоуреидо]-1,3-пропандиола для лечения HER2-положительных опухолей в эксперименте в дозе 15-20 мг/кг парентерально. Технический результат: у мышей FVB/N со спонтанным или перевиваемым HER2-положительным раком молочной железы 2-[3-(2-хлорэтил)-3-нитрозоуреидо]-1,3-пропандиол (внутрибрюшинно) однократно вызывал частичную и даже полную временную регрессию опухоли. Изобретение расширяет арсенал средств лечения HER2-положительных опухолей, повышает терапевтический эффект в подавлении роста опухоли. 2 ил., 6 табл., 3 пр.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2695787C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2695787C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2695787C13</originalsourceid><addsrcrecordid>eNqNyr0KwjAQAOAuDqK-w40K3mCLf2NpryaQ5sL1IoqIiMRJVNDJp3fxAZy-5etnn9gRcANqCCpuA0dfQ46HAsc5VsaxMKnZuwkW6K0KdxyFbM1HnE0LDMKh9FRbdtCwgAqVav0GDEmOgTurdkugsWXpgHaBxLbktXRuP8x61_PtlUY_Bxk0pJXB9Hyc0ut5vqR7ep8k5ov1fLlaVrPij_IFbJc6Yg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF THE COMPOUND 2-[3-(2-CHLOROETHYL)-3-NITROSOUREIDO]-1,3-PROPANEDIOL FOR TREATING HER2-POSITIVE TUMORS EXPERIMENTALLY</title><source>esp@cenet</source><creator>Vasileva Olesya Aleksandrovna ; Egormin Petr Andreevich ; Filatova Larisa Valentinovna ; Senchik Konstantin Yurevich ; Stukov Aleksandr Nikolaevich ; Bakhidze Elena Villevna ; Tochilnikov Grigorij Viktorovich ; Yurova Mariya Nikolaevna ; Semiglazova Tatyana Yurevna ; Bespalov Vladimir Grigorevich ; Majdin Mikhail Aleksandrovich ; Konstantinov Leonid Vladimirovich ; Panchenko Andrej Vladimirovich ; Plakhov Evgenij Aleksandrovich ; Tyndyk Margarita Leonidovna ; Poltoratskij Artem Nikolaevich ; Semenov Aleksandr Leonidovich ; Ivantsov Aleksandr Olegovich ; Vershinina Sofiya Fatkhutdinovna ; Latipova Dilorom Khamidovna ; Anisimov Vladimir Nikolaevich ; Chubenko Vyacheslav Andreevich ; Kozyavin Nikita Aleksandrovich ; Kireeva Galina Sergeevna</creator><creatorcontrib>Vasileva Olesya Aleksandrovna ; Egormin Petr Andreevich ; Filatova Larisa Valentinovna ; Senchik Konstantin Yurevich ; Stukov Aleksandr Nikolaevich ; Bakhidze Elena Villevna ; Tochilnikov Grigorij Viktorovich ; Yurova Mariya Nikolaevna ; Semiglazova Tatyana Yurevna ; Bespalov Vladimir Grigorevich ; Majdin Mikhail Aleksandrovich ; Konstantinov Leonid Vladimirovich ; Panchenko Andrej Vladimirovich ; Plakhov Evgenij Aleksandrovich ; Tyndyk Margarita Leonidovna ; Poltoratskij Artem Nikolaevich ; Semenov Aleksandr Leonidovich ; Ivantsov Aleksandr Olegovich ; Vershinina Sofiya Fatkhutdinovna ; Latipova Dilorom Khamidovna ; Anisimov Vladimir Nikolaevich ; Chubenko Vyacheslav Andreevich ; Kozyavin Nikita Aleksandrovich ; Kireeva Galina Sergeevna</creatorcontrib><description>FIELD: medicine.SUBSTANCE: invention relates to medicine, namely to oncology. Disclosed is use of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol for treating HER2-positive tumors experimentally in dose of 15-20 mg/kg parenterally.EFFECT: in mice FVB/N with spontaneous or transplantable HER2-positive breast cancer 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (intraperitoneally) once caused partial and even complete temporary regression of tumor; invention extends the range of products for treating HER2-positive tumors, increases the therapeutic effect in suppressing tumor growth.1 cl, 2 dwg, 6 tbl, 3 ex Изобретение относится к медицине, а именно к онкологии. Предложено применение 2-[3-(2-хлорэтил)-3-нитрозоуреидо]-1,3-пропандиола для лечения HER2-положительных опухолей в эксперименте в дозе 15-20 мг/кг парентерально. Технический результат: у мышей FVB/N со спонтанным или перевиваемым HER2-положительным раком молочной железы 2-[3-(2-хлорэтил)-3-нитрозоуреидо]-1,3-пропандиол (внутрибрюшинно) однократно вызывал частичную и даже полную временную регрессию опухоли. Изобретение расширяет арсенал средств лечения HER2-положительных опухолей, повышает терапевтический эффект в подавлении роста опухоли. 2 ил., 6 табл., 3 пр.</description><language>eng ; rus</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190726&amp;DB=EPODOC&amp;CC=RU&amp;NR=2695787C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190726&amp;DB=EPODOC&amp;CC=RU&amp;NR=2695787C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Vasileva Olesya Aleksandrovna</creatorcontrib><creatorcontrib>Egormin Petr Andreevich</creatorcontrib><creatorcontrib>Filatova Larisa Valentinovna</creatorcontrib><creatorcontrib>Senchik Konstantin Yurevich</creatorcontrib><creatorcontrib>Stukov Aleksandr Nikolaevich</creatorcontrib><creatorcontrib>Bakhidze Elena Villevna</creatorcontrib><creatorcontrib>Tochilnikov Grigorij Viktorovich</creatorcontrib><creatorcontrib>Yurova Mariya Nikolaevna</creatorcontrib><creatorcontrib>Semiglazova Tatyana Yurevna</creatorcontrib><creatorcontrib>Bespalov Vladimir Grigorevich</creatorcontrib><creatorcontrib>Majdin Mikhail Aleksandrovich</creatorcontrib><creatorcontrib>Konstantinov Leonid Vladimirovich</creatorcontrib><creatorcontrib>Panchenko Andrej Vladimirovich</creatorcontrib><creatorcontrib>Plakhov Evgenij Aleksandrovich</creatorcontrib><creatorcontrib>Tyndyk Margarita Leonidovna</creatorcontrib><creatorcontrib>Poltoratskij Artem Nikolaevich</creatorcontrib><creatorcontrib>Semenov Aleksandr Leonidovich</creatorcontrib><creatorcontrib>Ivantsov Aleksandr Olegovich</creatorcontrib><creatorcontrib>Vershinina Sofiya Fatkhutdinovna</creatorcontrib><creatorcontrib>Latipova Dilorom Khamidovna</creatorcontrib><creatorcontrib>Anisimov Vladimir Nikolaevich</creatorcontrib><creatorcontrib>Chubenko Vyacheslav Andreevich</creatorcontrib><creatorcontrib>Kozyavin Nikita Aleksandrovich</creatorcontrib><creatorcontrib>Kireeva Galina Sergeevna</creatorcontrib><title>USE OF THE COMPOUND 2-[3-(2-CHLOROETHYL)-3-NITROSOUREIDO]-1,3-PROPANEDIOL FOR TREATING HER2-POSITIVE TUMORS EXPERIMENTALLY</title><description>FIELD: medicine.SUBSTANCE: invention relates to medicine, namely to oncology. Disclosed is use of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol for treating HER2-positive tumors experimentally in dose of 15-20 mg/kg parenterally.EFFECT: in mice FVB/N with spontaneous or transplantable HER2-positive breast cancer 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (intraperitoneally) once caused partial and even complete temporary regression of tumor; invention extends the range of products for treating HER2-positive tumors, increases the therapeutic effect in suppressing tumor growth.1 cl, 2 dwg, 6 tbl, 3 ex Изобретение относится к медицине, а именно к онкологии. Предложено применение 2-[3-(2-хлорэтил)-3-нитрозоуреидо]-1,3-пропандиола для лечения HER2-положительных опухолей в эксперименте в дозе 15-20 мг/кг парентерально. Технический результат: у мышей FVB/N со спонтанным или перевиваемым HER2-положительным раком молочной железы 2-[3-(2-хлорэтил)-3-нитрозоуреидо]-1,3-пропандиол (внутрибрюшинно) однократно вызывал частичную и даже полную временную регрессию опухоли. Изобретение расширяет арсенал средств лечения HER2-положительных опухолей, повышает терапевтический эффект в подавлении роста опухоли. 2 ил., 6 табл., 3 пр.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyr0KwjAQAOAuDqK-w40K3mCLf2NpryaQ5sL1IoqIiMRJVNDJp3fxAZy-5etnn9gRcANqCCpuA0dfQ46HAsc5VsaxMKnZuwkW6K0KdxyFbM1HnE0LDMKh9FRbdtCwgAqVav0GDEmOgTurdkugsWXpgHaBxLbktXRuP8x61_PtlUY_Bxk0pJXB9Hyc0ut5vqR7ep8k5ov1fLlaVrPij_IFbJc6Yg</recordid><startdate>20190726</startdate><enddate>20190726</enddate><creator>Vasileva Olesya Aleksandrovna</creator><creator>Egormin Petr Andreevich</creator><creator>Filatova Larisa Valentinovna</creator><creator>Senchik Konstantin Yurevich</creator><creator>Stukov Aleksandr Nikolaevich</creator><creator>Bakhidze Elena Villevna</creator><creator>Tochilnikov Grigorij Viktorovich</creator><creator>Yurova Mariya Nikolaevna</creator><creator>Semiglazova Tatyana Yurevna</creator><creator>Bespalov Vladimir Grigorevich</creator><creator>Majdin Mikhail Aleksandrovich</creator><creator>Konstantinov Leonid Vladimirovich</creator><creator>Panchenko Andrej Vladimirovich</creator><creator>Plakhov Evgenij Aleksandrovich</creator><creator>Tyndyk Margarita Leonidovna</creator><creator>Poltoratskij Artem Nikolaevich</creator><creator>Semenov Aleksandr Leonidovich</creator><creator>Ivantsov Aleksandr Olegovich</creator><creator>Vershinina Sofiya Fatkhutdinovna</creator><creator>Latipova Dilorom Khamidovna</creator><creator>Anisimov Vladimir Nikolaevich</creator><creator>Chubenko Vyacheslav Andreevich</creator><creator>Kozyavin Nikita Aleksandrovich</creator><creator>Kireeva Galina Sergeevna</creator><scope>EVB</scope></search><sort><creationdate>20190726</creationdate><title>USE OF THE COMPOUND 2-[3-(2-CHLOROETHYL)-3-NITROSOUREIDO]-1,3-PROPANEDIOL FOR TREATING HER2-POSITIVE TUMORS EXPERIMENTALLY</title><author>Vasileva Olesya Aleksandrovna ; Egormin Petr Andreevich ; Filatova Larisa Valentinovna ; Senchik Konstantin Yurevich ; Stukov Aleksandr Nikolaevich ; Bakhidze Elena Villevna ; Tochilnikov Grigorij Viktorovich ; Yurova Mariya Nikolaevna ; Semiglazova Tatyana Yurevna ; Bespalov Vladimir Grigorevich ; Majdin Mikhail Aleksandrovich ; Konstantinov Leonid Vladimirovich ; Panchenko Andrej Vladimirovich ; Plakhov Evgenij Aleksandrovich ; Tyndyk Margarita Leonidovna ; Poltoratskij Artem Nikolaevich ; Semenov Aleksandr Leonidovich ; Ivantsov Aleksandr Olegovich ; Vershinina Sofiya Fatkhutdinovna ; Latipova Dilorom Khamidovna ; Anisimov Vladimir Nikolaevich ; Chubenko Vyacheslav Andreevich ; Kozyavin Nikita Aleksandrovich ; Kireeva Galina Sergeevna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2695787C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2019</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Vasileva Olesya Aleksandrovna</creatorcontrib><creatorcontrib>Egormin Petr Andreevich</creatorcontrib><creatorcontrib>Filatova Larisa Valentinovna</creatorcontrib><creatorcontrib>Senchik Konstantin Yurevich</creatorcontrib><creatorcontrib>Stukov Aleksandr Nikolaevich</creatorcontrib><creatorcontrib>Bakhidze Elena Villevna</creatorcontrib><creatorcontrib>Tochilnikov Grigorij Viktorovich</creatorcontrib><creatorcontrib>Yurova Mariya Nikolaevna</creatorcontrib><creatorcontrib>Semiglazova Tatyana Yurevna</creatorcontrib><creatorcontrib>Bespalov Vladimir Grigorevich</creatorcontrib><creatorcontrib>Majdin Mikhail Aleksandrovich</creatorcontrib><creatorcontrib>Konstantinov Leonid Vladimirovich</creatorcontrib><creatorcontrib>Panchenko Andrej Vladimirovich</creatorcontrib><creatorcontrib>Plakhov Evgenij Aleksandrovich</creatorcontrib><creatorcontrib>Tyndyk Margarita Leonidovna</creatorcontrib><creatorcontrib>Poltoratskij Artem Nikolaevich</creatorcontrib><creatorcontrib>Semenov Aleksandr Leonidovich</creatorcontrib><creatorcontrib>Ivantsov Aleksandr Olegovich</creatorcontrib><creatorcontrib>Vershinina Sofiya Fatkhutdinovna</creatorcontrib><creatorcontrib>Latipova Dilorom Khamidovna</creatorcontrib><creatorcontrib>Anisimov Vladimir Nikolaevich</creatorcontrib><creatorcontrib>Chubenko Vyacheslav Andreevich</creatorcontrib><creatorcontrib>Kozyavin Nikita Aleksandrovich</creatorcontrib><creatorcontrib>Kireeva Galina Sergeevna</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Vasileva Olesya Aleksandrovna</au><au>Egormin Petr Andreevich</au><au>Filatova Larisa Valentinovna</au><au>Senchik Konstantin Yurevich</au><au>Stukov Aleksandr Nikolaevich</au><au>Bakhidze Elena Villevna</au><au>Tochilnikov Grigorij Viktorovich</au><au>Yurova Mariya Nikolaevna</au><au>Semiglazova Tatyana Yurevna</au><au>Bespalov Vladimir Grigorevich</au><au>Majdin Mikhail Aleksandrovich</au><au>Konstantinov Leonid Vladimirovich</au><au>Panchenko Andrej Vladimirovich</au><au>Plakhov Evgenij Aleksandrovich</au><au>Tyndyk Margarita Leonidovna</au><au>Poltoratskij Artem Nikolaevich</au><au>Semenov Aleksandr Leonidovich</au><au>Ivantsov Aleksandr Olegovich</au><au>Vershinina Sofiya Fatkhutdinovna</au><au>Latipova Dilorom Khamidovna</au><au>Anisimov Vladimir Nikolaevich</au><au>Chubenko Vyacheslav Andreevich</au><au>Kozyavin Nikita Aleksandrovich</au><au>Kireeva Galina Sergeevna</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF THE COMPOUND 2-[3-(2-CHLOROETHYL)-3-NITROSOUREIDO]-1,3-PROPANEDIOL FOR TREATING HER2-POSITIVE TUMORS EXPERIMENTALLY</title><date>2019-07-26</date><risdate>2019</risdate><abstract>FIELD: medicine.SUBSTANCE: invention relates to medicine, namely to oncology. Disclosed is use of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol for treating HER2-positive tumors experimentally in dose of 15-20 mg/kg parenterally.EFFECT: in mice FVB/N with spontaneous or transplantable HER2-positive breast cancer 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (intraperitoneally) once caused partial and even complete temporary regression of tumor; invention extends the range of products for treating HER2-positive tumors, increases the therapeutic effect in suppressing tumor growth.1 cl, 2 dwg, 6 tbl, 3 ex Изобретение относится к медицине, а именно к онкологии. Предложено применение 2-[3-(2-хлорэтил)-3-нитрозоуреидо]-1,3-пропандиола для лечения HER2-положительных опухолей в эксперименте в дозе 15-20 мг/кг парентерально. Технический результат: у мышей FVB/N со спонтанным или перевиваемым HER2-положительным раком молочной железы 2-[3-(2-хлорэтил)-3-нитрозоуреидо]-1,3-пропандиол (внутрибрюшинно) однократно вызывал частичную и даже полную временную регрессию опухоли. Изобретение расширяет арсенал средств лечения HER2-положительных опухолей, повышает терапевтический эффект в подавлении роста опухоли. 2 ил., 6 табл., 3 пр.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; rus
recordid cdi_epo_espacenet_RU2695787C1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title USE OF THE COMPOUND 2-[3-(2-CHLOROETHYL)-3-NITROSOUREIDO]-1,3-PROPANEDIOL FOR TREATING HER2-POSITIVE TUMORS EXPERIMENTALLY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T13%3A03%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Vasileva%20Olesya%20Aleksandrovna&rft.date=2019-07-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2695787C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true